Dr. Michael Keating, a leading researcher from MD Anderson Cancer Center, has had a career that spans decades and has witnessed the evolution of CLL research. Andrew Schorr, the founder of Patient Power, sat down with Dr. Keating to discuss promising developments in CLL research and Dr. Keatings ongoing commitment: to stay alive until CLL is cured.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Advertisement